Trivalent immunization with metal-binding proteins confers protection against enterococci in a mouse infection model

Ling Ning Lam1, Angie Sedra2, Jessica Kajfasz1

  • 1Department of Oral Biology, College of Dentistry, University of Florida, Gainesville, FL 32610, United States.

FEMS Microbes
|November 11, 2024
PubMed

Insights

A multi-antigen vaccine targeting Enterococcus faecalis lipoproteins EfaA, AdcA, and AdcAII provides robust protection against systemic infections. This trivalent vaccine shows broad efficacy in preclinical models, offering a promising strategy against enterococcal pathogens.

Area of Science:

  • Microbiology and Immunology
  • Infectious Diseases
  • Vaccine Development

Background:

  • Enterococcus faecalis is a leading cause of nosocomial infections, including UTIs, wound infections, and endocarditis.
  • Previous studies identified EfaA (manganese/iron-binding) and AdcA/AdcAII (zinc-binding) lipoproteins as critical for E. faecalis virulence.
  • The potential of multi-valent immunization against systemic enterococcal infections remains largely unexplored.

Purpose of the Study:

  • To investigate whether a multi-valent immunization strategy can induce protective immunity against systemic Enterococcus faecalis infections.
  • To evaluate the synergistic effects of multi-antigen antibodies with host factors like calprotectin.
  • To assess the efficacy of passive and active immunization with multi-antigen vaccines in preclinical models.

Main Methods:

  • Generation of multi-antigen antisera against EfaA, AdcA, and AdcAII lipoproteins.
  • Assessment of opsonization capacity and synergistic effects with calprotectin in vitro.
  • Evaluation of passive immunization in Galleria mellonella and mouse peritonitis models.
  • Assessment of active immunization with a trivalent vaccine in mice challenged with E. faecalis and E. faecium.

Main Results:

  • Multi-antigen antisera mediated neutrophil opsonization similarly to single-antigen antisera.
  • Antigen-specific antibodies synergized with calprotectin to inhibit E. faecalis growth in vitro and in human serum.
  • Passive immunization with multi-antigen antisera provided robust protection in G. mellonella and moderate protection in mice.
  • Active immunization with a trivalent vaccine significantly protected mice against lethal E. faecalis infections, including against contemporary strains and E. faecium.

Conclusions:

  • A multi-valent immunization approach targeting EfaA, AdcA, and AdcAII lipoproteins is effective in inducing protective immunity against systemic Enterococcus faecalis infections.
  • The trivalent vaccine demonstrates broad efficacy, protecting against both E. faecalis and E. faecium, suggesting potential for broader enterococcal infection control.
  • This strategy represents a promising avenue for developing novel vaccines against challenging Gram-positive bacterial pathogens.

Related Concept Videos